LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
16,011,316
Share change
-261,736
Total reported value
$36,995,531
Price per share
$2.31
Number of holders
50
Value change
-$2,265,108
Number of buys
19
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q4 2021

As of 31 Dec 2021, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,011,316 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, SAMLYN CAPITAL, LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, BAKER BROS. ADVISORS LP, PLATINUM INVESTMENT MANAGEMENT LTD, FMR LLC, Eversept Partners, LP, and HARBOR CAPITAL ADVISORS, INC.. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.